Roger Dawson

First Name*

Last Name*

Email*

Phone*

Message*

I am authorized to claim this profile. I agree Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

First Name*

Last Name*

Email*

Phone*

Message*

Roger Dawson and Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

Contact Roger

Roger Dawson

Tissue-specific delivery of antibodies

Linkster Therapeutics AG

Roger has over 11 years of experience in research and drug development working at F. Hoffmann-La Roche. He contributed to the advancement of drug molecules as team player and leader of international and cross-functional teams. Inter alia, Roger served as head of translational protein science, project leader and implemented Roche’s ‘membrane protein platform’. As a renowned drug discovery expert, he led-authored numerous publications in the GPCR, ion channel and transporter field. Roger holds a master’s degree in Chemistry from the TUM and obtained his PhD in Biology at the ETH Zurich. He was awarded Roche’s RPF fellowship and the Swiss Federal Center of Technology and Innovation (Innosuisse) program.

Talks About
#antibodies #science

Preferred Locations
#Europe

Speaking Engagements

Protein Degraders and Molecular Glues – Part 1

Paid

A new generation of molecules are being developed to disrupt protein-protein interactions and to hijack the cell’s natural machinery for targeted protein degradation. Proteolysis-targeting chimeras (PROTACs), molecular glues, and other modalities are utilizing the ubiquitin-proteasome, lysosome, and autophagy systems to seek out previously “undrugg

26-27 September 2023

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER

Roger Dawson

Tissue-specific delivery of antibodies

Speaking Engagements

Protein Degraders and Molecular Glues – Part 1